Tratamiento médico versus intervencionista de la estenosis aterosclerótica de las arterias renales
Citas
Textor SC. Renovascular hypertension and ischemic nephropathy. En: Taal M, Brenner BM, Rector FC. Brenner & Rector’s the kidney. 9th ed. Philadelphia, PA: Elsevier-Saunders, 2012; cap. 45.
Cooper CJ, Murphy TP, Cutlip DE, Jamerson K, Henrich W, Reid DM, et al. Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med. 2014;370(1):13-22.
ASTRAL Investigators, Wheatley K, Ives N, Gray R, Kalra PA, Moss JG, et al. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med. 2009;361(20):1953-62.
Bax L, Woittiez AJ, Kouwenberg HJ, Mali WP, Buskens E, Beek FJ, et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Ann Intern Med. 2009;150(12):840-8, W150-1.
Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function--measured and estimated glomerular filtration rate. N Engl J Med. 2006;354(23):2473-83.
Imanishi M, Akabane S, Takamiya M, Kawamura M, Matsushima Y, Kuramochi M, et al. Critical degree of renal arterial stenosis that causes
hypertension in dogs. Angiology. 1992;43(10):833-42.
Bittl JA, Hirsch AT. Concomitant peripheral arterial disease and coronary artery disease: therapeutic opportunities. Circulation. 2004;109(25):3136-44.
Hansen KJ, Edwards MS, Craven TE, Cherr GS, Jackson SA, Appel RG, et al. Prevalence of renovascular disease in the elderly: a population-based study. J Vasc Surg. 2002;36(3):443-51.
